Health Care & Life Sciences » Biotechnology | Sorrento Therapeutics Inc.

Sorrento Therapeutics Inc.

Sorrento Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
116.73 M
Public Float
111.35 M
Sorrento Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.43
Market Cap
$295.55 M
Shares Outstanding
122.63 M
Public Float
95.18 M

Profile

Address
4955 Directors Place
San Diego California 92121
United States
Employees -
Website http://www.sorrentotherapeutics.com
Updated 07/08/2019
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H.

Financials

View All

Henry H. Ji
Chairman, President & Chief Executive Officer
Jaisim Shah
Director